Repaglinide Tablet
Product Images NDC 72603-811

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 72603-811). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Repaglinide Figure 1)

505 (Repaglinide Figure 1)
A line graph showing the change in HbA1c (%) over 24 treatment weeks comparing three groups: Repaglinide plus Pioglitazone, Repaglinide alone, and Pioglitazone alone. The y-axis represents the percentage change in HbA1c, and the x-axis represents the treatment weeks, illustrating a decreasing trend mostly in the combination treatment group.*
FDA Label Image

Str (Repaglinide Str)

Str (Repaglinide Str)
Chemical structure of Repaglinide showing its molecular arrangement including benzene rings, amide, and carboxylic acid functional groups.*
FDA Label Image

333 (Repaglinide Tablets 0 5mg 100s)

333 (Repaglinide Tablets 0 5mg 100s)
Label for Repaglinide Tablets USP 0.5 mg oral tablets, supplied in a container of 100 tablets. Label includes storage instructions, dosage reference, and manufacturer information for NorthStar Rx LLC and Macleods Pharmaceuticals Ltd., India. NDC 72603-810-01 is visible along with multiple barcodes.*
FDA Label Image

666 (Repaglinide Tablets 1mg 100s)

666 (Repaglinide Tablets 1mg 100s)
Repaglinide Tablets, USP 1 mg oral tablets packaging label from NorthStar Rx LLC. The label indicates 100 tablets per container, includes storage instructions (20° to 25°C), and child-resistant closure dispensing information. Manufactured by Macleods Pharmaceuticals Ltd. in India, the label also displays the NDC number 72603-811-01 and barcode.*
FDA Label Image

222 (Repaglinide Tablets 2mg 100s)

222 (Repaglinide Tablets 2mg 100s)
Label for Repaglinide Tablets, USP 2 mg, oral tablet form, containing 100 tablets per bottle. The label shows NorthStar Rx LLC as the labeler and indicates manufacturing by Macleods Pharmaceuticals Ltd. and Oxalis Labs, India. The label includes storage instructions and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.